Abstract
The known etiologies of acquired sensorineural hearing loss include acoustic trauma, physical trauma, ototoxicity, genetic predisposition, infections, Meniere’s disease, aging, and autoimmune disease. Treatments are directed at eliminating or managing the underlying disease process and aiding hearing with amplification. Rarely is it possible to improve unaided hearing after sensorineural loss except when the severe to profound level of loss is reached and cochlear implantation becomes an option. Autoimmune inner ear disease, however, is a treatable cause of sensorineural hearing loss and it is important for physicians and hearing health professionals to recognize that proper early diagnosis and management strategies may result in stabilization and possibly improvement in hearing.
Keywords
Hearing Loss Chronic Fatigue Syndrome Sensorineural Hearing Loss Cochlear Implantation Endolymphatic Hydrops
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 1.McCabe BF: Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979, 88:585.PubMedGoogle Scholar
- 2.Bachmeyer C, Leclerc-Landgraf N, Laurette F, et al.: Acute autoimmune sensorineural hearing loss associated with Chron’s disease. Am J Gastro 1998, 93(12):2565–2567.CrossRefGoogle Scholar
- 3.Kumar BN, Walsh RM, Wilson PS, Carlin WV: Sensorineural hearing loss and ulcerative colitis. J Laryn Otol 1997, 111(3):277–278.Google Scholar
- 4.Okamura H, Ohtani I, Anzai T: The hearing loss in Wegener’s granulomatosis: relationship between hearing loss and serum ANCA. Aurus Nasus Larynx 1992, 19(1):1–6.Google Scholar
- 5.Heller U, Becker EW, Zenner HP, Berg PA: Incidence and clinical relevance of antibodies to phospholipids, serotonin and ganglioside in patients with sudden deafness and progressive inner ear hearing loss. HNO 1998, 46(6):583–586.PubMedCrossRefGoogle Scholar
- 6.Trune DR, Kempton JB, Mitchell CR, Hefeneider SH: Failure of heat shock protein 70 antibodies to alter cochlear function in mice. Hear Res 1998, 116(1-2):65–70.PubMedCrossRefGoogle Scholar
- 7.Harris JP: Immunologic disorders affecting the ear. In Otolaryngology Head and Neck Surgery. Edited by Cummings CW et al. St. Louis: Mosby-Year Book Inc.; 1998:3172–3185.Google Scholar
- 8.Hirose K, Wener MH, Duckert LG: Utility of laboratory testing in autoimmune inner ear disease. Laryngoscope 1999, 109(11):1749–1754.PubMedCrossRefGoogle Scholar
- 9.Ottaviani F, Cadoni G, Marinelli L, et al.: Anti-endothelial autoantibodies in patients with sudden hearing loss. Laryngoscope 1999, 109(7):1084–1087.PubMedCrossRefGoogle Scholar
- 10.Yamawaki M, Ariga T, Gao Y, et al.: Sulfoglucuronsyl glycolipids as putative antigens for autoimmune inner ear disease. J Neuroimmunol 1998, 84(2):111–116.PubMedCrossRefGoogle Scholar
- 11.Nair TS, Prieskorn DM, Miller JM, et al.: In vivo binding and hearing loss after intracochlear infusion of KHRI-3 antibody. Hear Res 1997, 107(1-2):93–101.PubMedCrossRefGoogle Scholar
- 12.Disher MJ, Ramakrishnan A, Nair TS, et al.: Human autoantibodies and monoclonal antibody to KHRI-3 bind to a phylogenetically conserved inner-ear-supporting cell antigen. Ann NY Acad Sci 1997, 830:253–265.PubMedCrossRefGoogle Scholar
- 13.Nair TS, Prieskorn DM, Miller JM, et al.: KHRI-3 monoclonal antibody-induced damage to the inner ear: antibody staining of nascent scars. Hear Res 1999, 129(1-2):50–60.PubMedCrossRefGoogle Scholar
- 14.Rauch SD: Serum antibodies against heat shock protein 70 in Meniere’s disease. Am J Otol 1995, 16:648.PubMedGoogle Scholar
- 15.Harris JP, Aframiam D: Role of autoimunity in contralateral delayed endolymphatic hydrops. Am J Otol 1994, 15:710.PubMedGoogle Scholar
- 16.Iwai H, Tomoda K, Sugiura K, et al.: T cells infiltrating from the systemic circulation proliferate in the endolymphatic sac. Ann Otol Rhinol Laryngol 1999, 108(12):1146–1150.PubMedGoogle Scholar
- 17.Trune DR: Cochlear immunoglobulin in the C3H/lpr mouse model for autoimmune hearing loss. Otolaryngol Head Neck Surg 1997, 117(5):504–508.PubMedCrossRefGoogle Scholar
- 18.Wobig RJ, Kempton JB, Trune DR: Steroid-responsive cochlear dysfunction in the MRL/lpr autoimmune mouse. Otolaryngol. Head Neck Surg 1999, 121(4):344–347.CrossRefGoogle Scholar
- 19.Ruckenstein MJ, Sawar A, Hu L et al.: Effects of immunosuppression on the development of cochlear disease in the MRL-Fas(lpr) mouse. Laryngoscope 1999, 109(4):626–630.PubMedCrossRefGoogle Scholar
- 20.Inoue Y, Kanzaki J, Ogawa K, et al.: Hearing in the MRL/lpr mouse as a possible model of immune-mediated sensorineural hearing loss. Eur Arch Otorhinolaryngol 1998, 255(5):240–243.PubMedCrossRefGoogle Scholar
- 21.Keithley EM, Chen MC, Linthicum F: Clinical diagnoses associated with histologic findings of fibrotic tissue and new bone in the inner ear. Laryngoscope 1998, 108(1):87–91.PubMedCrossRefGoogle Scholar
- 22.Hoistad DL, Schachern PA, Paparella MM: Autoimmune sensorineural hearing loss: a human temporal bone study. Am J Otolaryn 1998, 19(1):33–39.CrossRefGoogle Scholar
- 23.Parnes LS, Sun AH, Freeman DJ: Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999, 109(7):1–17.PubMedCrossRefGoogle Scholar
- 24.Sismanis A, Wise CM, Johnson GD: Methotrexate management of immune mediated cochleovestibular disorders Otolarlyngol Head Neck Surg 1997, 116:146–152.CrossRefGoogle Scholar
- 25.Luetje CM, Berliner KI: Plasmaphoresis in autoimmnue inner ear disease: long-term follow-up. Am J Otol 1997, 18(5):572–6.PubMedGoogle Scholar
Copyright information
© Current Science Inc. 2000